Related Experiment Video
Updated: May 20, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Current treatment options for insomnia
1University of Miami Miller School of Medicine, Miami, Florida, USA. ubuford@med.miami.edu.
Physicians face challenges in treating insomnia due to its many causes. This review covers pharmacological and nonpharmacological insomnia treatments, emphasizing personalized care plans for patients.
Area of Science:
- Sleep Medicine
- Internal Medicine
Background:
- Insomnia is a common patient complaint that presents diagnostic and therapeutic challenges for physicians.
- The complexity arises from a wide range of potential underlying causes and diverse treatment options.
Purpose of the Study:
- To review current pharmacological and nonpharmacological interventions for insomnia.
- To highlight the necessity of individualized assessment and treatment strategies for sleep disturbances.
Main Methods:
- Literature review of available scientific evidence on insomnia treatments.
- Synthesis of data on pharmacological agents and nonpharmacological approaches.
- Emphasis on patient-specific factors in treatment planning.
Main Results:
- Pharmacological options offer various mechanisms for managing insomnia symptoms.
- Nonpharmacological interventions provide alternative or complementary therapeutic strategies.
- Effective insomnia management requires a holistic approach considering patient lifestyle and sleep patterns.
Conclusions:
- A comprehensive, patient-tailored assessment is crucial for effective insomnia management.
- Integrating pharmacological and nonpharmacological treatments can optimize patient outcomes.
- Understanding individual sleep disturbance characteristics guides specialized treatment plans.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Antidepressant Drugs: MAOIs and Other Agents